| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | N05CH01 |
| UNII: | JL5DK93RCL |
| InChI Key | DRLFMBDRBRZALE-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C13H16N2O2 |
| Molecular Weight | 232.28 |
| AlogP | 1.86 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 54.12 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 17.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Melatonin receptor agonist | Other |
| Primary Target | |
|---|---|
| MT1 receptor | |
| MT2 receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1A
Cytochrome P450 1A1
|
- | - | - | 59000 | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1A
Cytochrome P450 1A2
|
- | - | - | 12000 | - | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1B
Cytochrome P450 1B1
|
- | - | - | 14000 | - | |
|
Enzyme
Hydrolase
|
- | - | - | - | 1 | |
|
Enzyme
Oxidoreductase
|
- | 65-11300 | - | 28-57 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine-derivative receptor (family A GPCR)
Melatonin receptor
|
0-25 | 0-1 | 0 | 0-1 | 100 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Histamine receptor
|
- | - | - | 1 | - | |
|
Membrane receptor
|
0-25 | 0-1 | 0 | 0-1 | 19-49 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 71 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Barrett Esophagus | 3 | D001471 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Migraine Disorders | 3 | D008881 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Anxiety | 3 | D001007 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Attention Deficit Disorder with Hyperactivity | 3 | D001289 | ClinicalTrials |
| Sleep Initiation and Maintenance Disorders | 3 | D007319 | ClinicalTrials |
| Child Development Disorders, Pervasive | 3 | D002659 | ClinicalTrials |
| Tooth Diseases | 3 | D014076 | ClinicalTrials |
| Gastroesophageal Reflux | 3 | D005764 | ClinicalTrials |
| Irritable Bowel Syndrome | 3 | D043183 | ClinicalTrials |
| Dementia | 3 | D003704 | ClinicalTrials |
| Delirium | 3 | D003693 | ClinicalTrials |
| Sleep Wake Disorders | 3 | D012893 | ClinicalTrials |
| Squamous Cell Carcinoma of Head and Neck | 3 | D000077195 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Enuresis | 2 | D004775 | ClinicalTrials |
| Aortic Aneurysm | 2 | D001014 | ClinicalTrials |
| Metabolic Syndrome | 2 | D024821 | ClinicalTrials |
| Dermatitis, Atopic | 2 | D003876 | ClinicalTrials |
| Epilepsy | 2 | D004827 | ClinicalTrials |
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
| Hypertension | 2 | D006973 | ClinicalTrials |
| Multiple Sclerosis, Relapsing-Remitting | 2 | D020529 | ClinicalTrials |
| Atrial Fibrillation | 2 | D001281 | ClinicalTrials |
| Hemorrhage | 2 | D006470 | ClinicalTrials |
| Autistic Disorder | 2 | D001321 | ClinicalTrials |
| Pain | 2 | D010146 | ClinicalTrials |
| Cognitive Dysfunction | 2 | D060825 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Reperfusion Injury | 2 | D015427 | ClinicalTrials |
| Fibromyalgia | 2 | D005356 | ClinicalTrials |
| Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
| Burns | 2 | D002056 | ClinicalTrials |
| Prediabetic State | 2 | D011236 | ClinicalTrials |
| Fatigue | 2 | D005221 | ClinicalTrials |
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Alcohol-Related Disorders | 2 | D019973 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Periodontitis | 2 | D010518 | ClinicalTrials |
| Myocardial Infarction | 2 | D009203 | ClinicalTrials |
| Substance Withdrawal Syndrome | 1 | D013375 | ClinicalTrials |
| Hypoxia-Ischemia, Brain | 1 | D020925 | ClinicalTrials |
| Postpartum Hemorrhage | 1 | D006473 | ClinicalTrials |
| Skin Diseases | 1 | D012871 | ClinicalTrials |
| Stomatitis | 1 | D013280 | ClinicalTrials |
| Hot Flashes | 1 | D019584 | ClinicalTrials |
| Periodontal Diseases | 1 | D010510 | ClinicalTrials |
| Brain Ischemia | 1 | D002545 | ClinicalTrials |
| Metabolic Diseases | 1 | D008659 | ClinicalTrials |
| Multiple Sclerosis | 1 | D009103 | ClinicalTrials |
| Sepsis | 1 | D018805 | ClinicalTrials |
| Neonatal Sepsis | 1 | D000071074 | ClinicalTrials |
| Sunburn | 1 | D013471 | ClinicalTrials |
| Bone Diseases, Metabolic | 0 | D001851 | ClinicalTrials |
| Diabetes Mellitus | 0 | D003920 | ClinicalTrials |
| Sleep Apnea, Obstructive | 0 | D020181 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 73-31-4 |
| ChEBI | 16796 |
| ChEMBL | CHEMBL45 |
| DrugBank | DB01065 |
| DrugCentral | 1672 |
| EPA CompTox | DTXSID1022421 |
| FDA SRS | JL5DK93RCL |
| Human Metabolome Database | HMDB0001389 |
| Guide to Pharmacology | 1357 |
| KEGG | C01598 |
| PDB | ML1 |
| PharmGKB | PA164752558 |
| PubChem | 896 |
| SureChEMBL | SCHEMBL19018 |
| ZINC | ZINC000000057060 |